Utah Historical Cash Flow
| UTMD Stock | USD 63.84 0.10 0.16% |
Analysis of Utah Medical cash flow over time is an excellent tool to project Utah Medical Products future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Change In Cash of 18.7 M or Stock Based Compensation of 236.2 K as it is a great indicator of Utah Medical ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Utah Medical Products latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Utah Medical Products is a good buy for the upcoming year.
Utah |
About Utah Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Utah balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Utah's non-liquid assets can be easily converted into cash.
Utah Medical Cash Flow Chart
Add Fundamental
Change To Inventory
The increase or decrease in the amount of inventory a company has over a certain period.Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Change In Working Capital
The difference in the amount of working capital from one period to the next, indicating the change in a company's short-term assets and liabilities.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Net Income
Net income is one of the most important fundamental items in finance. It plays a large role in Utah Medical Products financial statement analysis. It represents the amount of money remaining after all of Utah Medical Products operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Most accounts from Utah Medical's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Utah Medical Products current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Utah Medical Products. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. At present, Utah Medical's Stock Based Compensation is projected to increase significantly based on the last few years of reporting. The current year's Free Cash Flow is expected to grow to about 22.7 M, whereas Change To Inventory is projected to grow to (636.5 K).
Utah Medical cash flow statement Correlations
Click cells to compare fundamentals
Utah Medical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Utah Medical cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Sale Purchase Of Stock | (1.2M) | (398K) | (7.0M) | (2.5M) | (2.9M) | (3.0M) | |
| Change To Inventory | (1.7M) | 924K | (485K) | (2.4M) | (670K) | (636.5K) | |
| Change In Cash | (8.3M) | 8.8M | 9.4M | 14.1M | 17.8M | 18.7M | |
| Stock Based Compensation | 113K | 160K | 166K | 183K | 225K | 236.3K | |
| Free Cash Flow | (4.5M) | 19.3M | 20.7M | 20.3M | 21.6M | 22.7M | |
| Change In Working Capital | (4.3M) | 2.0M | (1.0M) | (2.2M) | (233K) | (221.4K) | |
| Begin Period Cash Flow | 51.1M | 42.8M | 51.6M | 61.0M | 75.1M | 78.8M | |
| Other Cashflows From Financing Activities | 283K | 358K | 13.8M | (818K) | 117K | 122.9K | |
| Depreciation | 6.9M | 7.2M | 7.3M | 7.1M | 6.4M | 6.7M | |
| Other Non Cash Items | 53K | 3K | 63K | 36K | (33K) | (31.4K) | |
| Capital Expenditures | 21.5M | 860K | 552K | 818K | 639K | 607.1K | |
| Total Cash From Operating Activities | 17.1M | 20.1M | 21.2M | 21.1M | 22.3M | 12.7M | |
| Net Income | 14.7M | 10.8M | 14.8M | 16.5M | 16.6M | 10.1M | |
| Total Cash From Financing Activities | (4.2M) | (10.7M) | (10.9M) | (5.5M) | (4.2M) | (4.4M) | |
| End Period Cash Flow | 42.8M | 51.6M | 61.0M | 75.1M | 92.9M | 97.5M | |
| Dividends Paid | 4.1M | 4.1M | 11.5M | 3.2M | 4.3M | 4.2M | |
| Change To Account Receivables | (738K) | 617K | (1.1M) | (511K) | 2.3M | 2.4M | |
| Change To Liabilities | (1.5M) | (308K) | 690K | 716K | 644.4K | 522.7K | |
| Total Cashflows From Investing Activities | (21.5M) | (860K) | (552K) | (818K) | (736.2K) | (773.0K) | |
| Investments | (21.5M) | (860K) | (552K) | (818K) | (587K) | (616.4K) | |
| Change Receivables | (754K) | 662K | (1.1M) | (525K) | (472.5K) | (448.9K) | |
| Exchange Rate Changes | (1.4M) | 386K | 260K | (362K) | (416.3K) | (437.1K) | |
| Cash And Cash Equivalents Changes | (8.3M) | 8.8M | 9.4M | 14.8M | 17.1M | 17.9M | |
| Cash Flows Other Operating | (308K) | 147K | (78K) | (11K) | (12.7K) | (12.0K) | |
| Change To Netincome | (3.4M) | (230K) | 137K | (182K) | (163.8K) | (172.0K) | |
| Change To Operating Activities | (2.0M) | 760K | 590K | 174K | 156.6K | 148.8K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Utah Medical Products is a strong investment it is important to analyze Utah Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Utah Medical's future performance. For an informed investment choice regarding Utah Stock, refer to the following important reports:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Utah Medical Products. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Utah Medical. If investors know Utah will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Utah Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.05) | Dividend Share 1.2 | Earnings Share 4.28 | Revenue Per Share 12.392 | Quarterly Revenue Growth (0.20) |
The market value of Utah Medical Products is measured differently than its book value, which is the value of Utah that is recorded on the company's balance sheet. Investors also form their own opinion of Utah Medical's value that differs from its market value or its book value, called intrinsic value, which is Utah Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Utah Medical's market value can be influenced by many factors that don't directly affect Utah Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Utah Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Utah Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Utah Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.